Cargando…

The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income Country

Rotavirus vaccination was introduced in high-income countries starting in 2006, with no recommendation for optimal implementation. Economic evaluations were presented before launch projecting potential impacts. Few economic reassessments have been reported following reimbursement. This study compare...

Descripción completa

Detalles Bibliográficos
Autor principal:	Standaert, Baudouin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223627/ https://www.ncbi.nlm.nih.gov/pubmed/37243021 http://dx.doi.org/10.3390/vaccines11050917

Ejemplares similares

Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in Europe
por: Standaert, Baudouin, et al.
Publicado: (2022)

Lessons Learned from Long-Term Assessment of Rotavirus Vaccination in a High-Income Country: The Case of the Rotavirus Vaccine Belgium Impact Study (RotaBIS)
por: Standaert, Baudouin, et al.
Publicado: (2020)

Improving the Hospital Quality of Care during Winter Periods by Optimizing Budget Allocation Between Rotavirus Vaccination and Bed Expansion
por: Dort, Thibaut, et al.
Publicado: (2017)

Medium- to Long-Term Impact of Rotavirus Vaccination on Hospital Care in Belgium: A 7-Year Follow-Up of the Rotavirus Belgium Impact Study (RotaBIS)
por: Standaert, Baudouin, et al.
Publicado: (2015)

Rotavirus vaccine protection in low-income and middle-income countries
por: Ramakrishnan, Girija, et al.
Publicado: (2019)

Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?
por: Knoll, Stefanie, et al.
Publicado: (2013)

Towards a more comprehensive approach for a total economic assessment of vaccines?: 1. The building blocks for a health economic assessment of vaccination
por: Standaert, Baudouin, et al.
Publicado: (2017)

2. How is the economic assessment of vaccines performed today?
por: Standaert, Baudouin, et al.
Publicado: (2017)

3. How comprehensive can we be in the economic assessment of vaccines?
por: Standaert, Baudouin, et al.
Publicado: (2017)

Measuring indirect effects of rotavirus vaccine in low income countries
por: Bennett, Aisleen, et al.
Publicado: (2016)

Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990
por: Standaert, Baudouin
Publicado: (2023)

Impact of Rotavirus Vaccination on Hospitalisations in Belgium: Comparing Model Predictions with Observed Data
por: Standaert, Baudouin, et al.
Publicado: (2013)

Exploring the potential impact of rotavirus vaccination on work absenteeism among female administrative personnel of the City of Antwerp through a retrospective database analysis
por: Standaert, Baudouin, et al.
Publicado: (2015)

The Sustained Rotavirus Vaccination Impact on Nosocomial Infection, Duration of Hospital Stay, and Age: The RotaBIS Study (2005–2012)
por: Standaert, Baudouin, et al.
Publicado: (2016)

Health and economic impact of rotavirus vaccination in GAVI-eligible countries
por: Kim, Sun-Young, et al.
Publicado: (2010)

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries
por: Marijam, Alen, et al.
Publicado: (2022)

How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future
por: Standaert, Baudouin, et al.
Publicado: (2020)

Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines
por: Lee, Benjamin
Publicado: (2020)

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2021)

Systematic Review and Meta-Analysis of Cost-effectiveness of Rotavirus Vaccine in Low-Income and Lower-Middle-Income Countries
por: Haider, Sabbir, et al.
Publicado: (2019)

Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries
por: Damm, Oliver, et al.
Publicado: (2015)

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world
por: Postma, Maarten J, et al.
Publicado: (2011)

Public health impact of accelerated immunization against rotavirus infection among children aged less than 6 months in the United States
por: Weycker, Derek, et al.
Publicado: (2014)

Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework
por: Carvalho, Natalie, et al.
Publicado: (2017)

Rotavirus Vaccine Schedules and Vaccine Response Among Infants in Low- and Middle-Income Countries: A Systematic Review
por: Gruber, Joann F., et al.
Publicado: (2017)

Balancing safety, efficacy and cost: Improving rotavirus vaccine adoption in low- and middle-income countries
por: Bhan, Anant, et al.
Publicado: (2011)

Economic Impact of a Rotavirus Vaccine in Brazil
por: Constenla, Dagna O., et al.
Publicado: (2008)

Comparing Cost-Effectiveness Results for a Vaccine Across Different Countries Worldwide: What Can We Learn?
por: Standaert, Baudouin, et al.
Publicado: (2014)

Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?
por: Steele, A.D., et al.
Publicado: (2019)

Economic evaluation of rotavirus vaccination in children of Bhutan
por: Pempa, et al.
Publicado: (2020)

Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries
por: Mooney, Jessica, et al.
Publicado: (2022)

Pneumococcal conjugate vaccine implementation in middle-income countries
por: Tricarico, Serena, et al.
Publicado: (2017)

Do hospital pressures change following rotavirus vaccine introduction? A retrospective database analysis in a large paediatric hospital in the UK
por: Heinsbroek, Ellen, et al.
Publicado: (2019)

Understanding Rotavirus Vaccine Efficacy and Effectiveness in Countries with High Child Mortality
por: Varghese, Tintu, et al.
Publicado: (2022)

Introducing Rotavirus Vaccination in Nigeria: Economic Evaluation and Implications
por: Okafor, Charles Ebuka
Publicado: (2021)

Italian Physicians’ Opinions on Rotavirus Vaccine Implementation
por: Mita, Valentin, et al.
Publicado: (2017)

Rotavirus vaccine implementation: evidence to fill the gap?
por: Buttery, Jim P, et al.
Publicado: (2021)

Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries
por: Boujaoude, Marie-Anne, et al.
Publicado: (2018)

Rotaviruses and Rotavirus Vaccines
por: Donato, Celeste M., et al.
Publicado: (2021)

Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study
por: Riumallo-Herl, Carlos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6a1a039up566vek88b148af52d